Crystal Tran

Crystal Tran practices at Ocean Skin and Vein Institute in Pacific Palisades, California.

Crystal Tran's NPI, 1538898853, was assigned on June 10, 2022.

Crystal Tran's primary practice is Ocean Skin and Vein Institute, at 932 N Rivas Canyon Rd, Pacific Palisades, CA 90272 in Los Angeles County. The practice phone is (310) 847-9693.

Crystal Tran's primary practice is Ocean Skin and Vein Institute in Pacific Palisades, California. The medical group on file is Ocean Skin and Vein Institute. Dmand AI also links Crystal Tran to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Crystal Tran practices. Vendor and product names are available with a free account.

Physician assistant is Crystal Tran's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

CMS data shows 615 Medicare services from Crystal Tran across 8 procedure codes in 2024, for 185 Medicare patients. Medicare paid $27,534 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Crystal Tran in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Crystal Tran's median patient age at 52, with 58% women.

In 2024, Crystal Tran wrote 300 Medicare Part D claims for 130 patients. 99% of them were for generic drugs. CMS names the drug for 240 of them, across 10 drugs with 11 or more claims each, at $9,435 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Crystal Tran for performance year 2024, reported as part of a group. Crystal Tran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Crystal Tran from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $28.